These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Criteria-based DUE aids in selection of preferred agent. Drea EJ Hosp Formul; 1991 Nov; 26 Suppl D():25-7. PubMed ID: 10136562 [TBL] [Abstract][Full Text] [Related]
9. Strategy for developing a safe and cost-effective H2-receptor antagonist program. Quercia RA; Chow MS; Jay GT; Quintiliani R Hosp Formul; 1991 Nov; 26 Suppl D():20-4. PubMed ID: 10136561 [TBL] [Abstract][Full Text] [Related]
10. Use of concurrent monitoring and a preprinted note to modify prescribing of i.v. cimetidine and ranitidine in a teaching hospital. Dannenhoffer MA; Slaughter RL; Hunt SN Am J Hosp Pharm; 1989 Aug; 46(8):1570-5. PubMed ID: 2773962 [TBL] [Abstract][Full Text] [Related]
11. Reducing costs with formulary limitation of H2-receptor antagonists in a community hospital. Coppola P Hosp Pharm; 1991 Feb; 26(2):126-9, 142. PubMed ID: 10136547 [TBL] [Abstract][Full Text] [Related]
12. Use of H2-receptor antagonists in children. Dimand RJ DICP; 1990 Nov; 24(11 Suppl):S42-6. PubMed ID: 2270695 [TBL] [Abstract][Full Text] [Related]
13. Drug usage evaluation: H2-receptor antagonist use in 30 hospitals. Kowalsky SF; Hamilton RA; Figge HL Hosp Formul; 1991 Sep; 26(9):725-6, 732, 734-6 passim. PubMed ID: 10114004 [TBL] [Abstract][Full Text] [Related]
14. Implementing therapeutic interchange of intravenous famotidine for cimetidine and ranitidine. Oh T; Franko TG Am J Hosp Pharm; 1990 Jul; 47(7):1547-51. PubMed ID: 2114789 [TBL] [Abstract][Full Text] [Related]
15. Experience with a two-tiered therapeutic interchange policy. Rich DS Am J Hosp Pharm; 1989 Sep; 46(9):1792-8. PubMed ID: 2572167 [TBL] [Abstract][Full Text] [Related]
16. A comparative evaluation of cimetidine and ranitidine. Zimmerman TW; Schenker S Ration Drug Ther; 1985 Apr; 19(4):1-7. PubMed ID: 2932770 [No Abstract] [Full Text] [Related]